WePN-DA: Westlake Personalized Nutrition and Health Cohort for Drug Addicts

Sponsor
Westlake University (Other)
Overall Status
Completed
CT.gov ID
NCT04105621
Collaborator
Zhejiang Drug Rehabilitation Administration (Other)
228
1
14.8
15.4

Study Details

Study Description

Brief Summary

This is a prospective cohort study of drug addicts confined in Zhejiang rehabilitation centers. The primary aim of this study is to investigate the association between diet and health status among drug addicts. The second aim is to characterize the continuous blood glucose response to dietary intakes over 2 weeks. The third aim is to describe the dynamic changes of gut microbiota at three time points in drug addicts during compulsory detoxification and to evaluate the association between gut microbiota, diet and addiction severity.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Over recent decades, there is a growing trend of drug addiction in China that poses great public health challenges. Drug abuse can lead to many health related problems such as malnutrition and mental disorders along with reduced quality of life. Dietary intervention plays a pivotal role in disease prevention and drug rehabilitation for drug addicts, but the associations between dietary intake and health related outcomes among drug addicts remain unclear.

    In addition, the relationship between the human gut microbiota and its response to addictive drugs as a newly arisen subject is given wide attention in recent years. However, the underlying mechanism requires further investigation. The dynamic changes of gut microbiota among drug addicts during compulsory drug rehabilitation period are in vague.

    Under the same diet exposure, different drug addicts may have different blood glucose responses as well as gut microbiota profiles. Therefore, in order to examine the association between diet, gut microbiota and drug addiction, our study design will include three components: (1) the measurement of dietary intake using FFQ while the menu offered by drug rehabilitation center and food diary; (2) the measurements of blood glucose over 2 weeks using continuous glucose monitors; and (3) the measurements of gut microbiota at three time points using 16s rRNA sequencing techniques.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    228 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Westlake Personalized Nutrition and Health Cohort for Drug Addicts
    Actual Study Start Date :
    Oct 28, 2019
    Actual Primary Completion Date :
    Jan 20, 2021
    Actual Study Completion Date :
    Jan 20, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Drug addicts

    This group included drug addicts lived in drug rehablitation center.

    Healthy population

    We recruited the healthy participants from the Westlake N-of-1 Trials for Macronutrient Intake (NCT04125602) as healthy control

    Outcome Measures

    Primary Outcome Measures

    1. Continuous blood glucose profile over 2 weeks [Two weeks after enrollment]

      Glucose levels were measured using continuous glucose monitoring over 2 week

    2. The dynamic change of gut microbiota within one year [One year after enrollment; includes three sampling time points: baseline, 6 months after enrollment and 12 months after enrollment.]

      Fecal microbiota was analyzed using16S rRNA gene sequencing technique

    Secondary Outcome Measures

    1. Drug craving intensity [Baseline; 6 months after enrollment; 12 months after enrollment]

      This was evaluated by Obsessive Compulsive Drug Use Scale (OCDUS). This scale had 13 items, each with a 5-point Likert-response (1, 2, 3, 4 and 5). Items 6 and 13 were reverse-scored. The total score ranges from 13 to 65 and a higher value represent a higher intensity of drug craving.

    2. The change of BMI [Baseline; 6 months after enrollment; 12 months after enrollment]

      BMI in kg/m^2

    3. Nutritional status [Baseline; 6 months after enrollment; 12 months after enrollment]

      Nutritional status was measured by mini nutritional assessment (MNA) screening test.

    4. The degree of depression [Baseline; 6 months after enrollment; 12 months after enrollment]

      This was evaluated by Beck Depression Inventory-II (BDI-II). Scores in every item of the BDI-II were between 0 and 3. The total score ranges from 0 to 63.

    5. The degree of anxiety [Baseline; 6 months after enrollment; 12 months after enrollment]

      This was evaluated by Hamilton Anxiety Scale (HAMA). Scores in every item of the HAMA were between 0 and 4. The total score ranges from 0 to 56.

    6. Body composition [Baseline; 6 months after enrollment; 12 months after enrollment]

      Body composition (fat mass, lean mass in kg ) are assessed by bioelectrical impedance analysis.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Drug addicts aged between 18 yrs and 65yrs.

    • Drug addicts lived in Zhejiang drug rehabilitation centers.

    • Drug addicts who have stayed in drug rehabilitation center for no more than 6 months.

    Exclusion Criteria:
    • Drug addicts diagnosed with cancer or other serious physical and mental disorders.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zhejiang Drug Rehabilitation Administration Hangzhou Zhejiang China 310008

    Sponsors and Collaborators

    • Westlake University
    • Zhejiang Drug Rehabilitation Administration

    Investigators

    • Principal Investigator: Ju-Sheng Zheng, PhD, Westlake University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Westlake University
    ClinicalTrials.gov Identifier:
    NCT04105621
    Other Study ID Numbers:
    • 20190812ZJS0009
    First Posted:
    Sep 26, 2019
    Last Update Posted:
    Apr 14, 2021
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Westlake University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 14, 2021